Related Experiment Video

Updated: Aug 15, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

[Role of Chlamydia pneumoniae in the pathogenesis of coronary disease]

J Kähler1, R Köster, J H Bräser

  • 1Abteilung für Kardiologie, Universitäts-Krankenhaus Eppendorf, Hamburg.

Zeitschrift Fur Kardiologie
|January 22, 2000
PubMed

Insights

Chlamydia pneumoniae infection is linked to a twofold increased risk of coronary artery disease. This chronic inflammatory process may contribute to atherosclerosis development through various mechanisms.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathology

Background:

  • Coronary artery disease (CAD) is a major global health concern.
  • Atherosclerosis, the underlying pathology of CAD, is increasingly recognized as a chronic inflammatory process.
  • Emerging evidence suggests infectious agents may play a role in atherosclerosis development.

Purpose of the Study:

  • To review the current knowledge on the association between Chlamydia pneumoniae and coronary artery disease.
  • To discuss potential pathomechanisms linking C. pneumoniae infection to atherosclerosis.
  • To evaluate the etiological role of C. pneumoniae in CAD.

Main Methods:

  • Literature review of studies investigating Chlamydia pneumoniae and coronary artery disease.
  • Analysis of proposed pathomechanisms, including cytokine synthesis and cellular effects.
  • Examination of findings from animal models and clinical trials involving antibiotic therapy.

Main Results:

  • Multiple studies indicate an association between C. pneumoniae infection and increased risk of CAD (odds ratio >= 2).
  • Pathomechanisms proposed include C. pneumoniae-induced cytokine synthesis, proliferative, and proaggregatory effects.
  • Preliminary clinical trials and animal models suggest a potential etiological role for C. pneumoniae.

Conclusions:

  • Chlamydia pneumoniae infection is associated with an increased risk of coronary artery disease.
  • The infection may contribute to atherosclerosis through inflammatory and cellular mechanisms.
  • Further research and clinical trials are warranted to confirm the etiological role and explore therapeutic interventions.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...